These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37198279)

  • 1. Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.
    Montoliu-Gaya L; Benedet AL; Tissot C; Vrillon A; Ashton NJ; Brum WS; Lantero-Rodriguez J; Stevenson J; Nilsson J; Sauer M; Rahmouni N; Brinkmalm G; Lussier FZ; Pascoal TA; Skoog I; Kern S; Zetterberg H; Paquet C; Gobom J; Rosa-Neto P; Blennow K
    Nat Aging; 2023 Jun; 3(6):661-669. PubMed ID: 37198279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
    Montoliu-Gaya L; Alosco ML; Yhang E; Tripodis Y; Sconzo D; Ally M; Grötschel L; Ashton NJ; Lantero-Rodriguez J; Sauer M; Gomes B; Nilsson J; Brinkmalm G; Sugarman MA; Aparicio HJ; Martin B; Palmisano JN; Steinberg EG; Simkin I; Turk KW; Budson AE; Au R; Farrer L; Jun GR; Kowall NW; Stern RA; Goldstein LE; Qiu WQ; Mez J; Huber BR; Alvarez VE; McKee AC; Zetterberg H; Gobom J; Stein TD; Blennow K
    Acta Neuropathol; 2023 Dec; 147(1):5. PubMed ID: 38159140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated tau in Alzheimer's disease.
    Telser J; Grossmann K; Wohlwend N; Risch L; Saely CH; Werner P
    Adv Clin Chem; 2023; 116():31-111. PubMed ID: 37852722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
    Therriault J; Servaes S; Tissot C; Rahmouni N; Ashton NJ; Benedet AL; Karikari TK; Macedo AC; Lussier FZ; Stevenson J; Wang YT; Fernandez-Arias J; Stevenson A; Socualaya KQ; Haeger A; Nazneen T; Aumont É; Hosseini A; Rej S; Vitali P; Triana-Baltzer G; Kolb HC; Soucy JP; Pascoal TA; Gauthier S; Zetterberg H; Blennow K; Rosa-Neto P
    Alzheimers Dement; 2023 Nov; 19(11):4967-4977. PubMed ID: 37078495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
    Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Janelidze S; Zetterberg H; Scheffler M; Assal F; Garibotto V; Blennow K; Hansson O; Frisoni GB
    J Neurol; 2024 Apr; 271(4):2053-2066. PubMed ID: 38195896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Lantero-Rodriguez J; Montoliu-Gaya L; Benedet AL; Vrillon A; Dumurgier J; Cognat E; Brum WS; Rahmouni N; Stevenson J; Servaes S; Therriault J; Becker B; Brinkmalm G; Snellman A; Huber H; Kvartsberg H; Ashton NJ; Zetterberg H; Paquet C; Rosa-Neto P; Blennow K
    Acta Neuropathol; 2024 Jan; 147(1):12. PubMed ID: 38184490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
    Leuzy A; Janelidze S; Mattsson-Carlgren N; Palmqvist S; Jacobs D; Cicognola C; Stomrud E; Vanmechelen E; Dage JL; Hansson O
    Neurology; 2021 Oct; 97(17):e1681-e1694. PubMed ID: 34493616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
    Bayoumy S; Verberk IMW; den Dulk B; Hussainali Z; Zwan M; van der Flier WM; Ashton NJ; Zetterberg H; Blennow K; Vanbrabant J; Stoops E; Vanmechelen E; Dage JL; Teunissen CE
    Alzheimers Res Ther; 2021 Dec; 13(1):198. PubMed ID: 34863295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O
    Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.
    Kac PR; González-Ortiz F; Emeršič A; Dulewicz M; Koutarapu S; Turton M; An Y; Smirnov D; Kulczyńska-Przybik A; Varma VR; Ashton NJ; Montoliu-Gaya L; Camporesi E; Winkel I; Paradowski B; Moghekar A; Troncoso JC; Lashley T; Brinkmalm G; Resnick SM; Mroczko B; Kvartsberg H; Gregorič Kramberger M; Hanrieder J; Čučnik S; Harrison P; Zetterberg H; Lewczuk P; Thambisetty M; Rot U; Galasko D; Blennow K; Karikari TK
    Nat Commun; 2024 Mar; 15(1):2615. PubMed ID: 38521766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease.
    Lim YY; Maruff P; Barthélemy NR; Goate A; Hassenstab J; Sato C; Fagan AM; Benzinger TLS; Xiong C; Cruchaga C; Levin J; Farlow MR; Graff-Radford NR; Laske C; Masters CL; Salloway S; Schofield PR; Morris JC; Bateman RJ; McDade E;
    JAMA Neurol; 2022 Mar; 79(3):261-270. PubMed ID: 35099506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.
    Yu L; Boyle PA; Janelidze S; Petyuk VA; Wang T; Bennett DA; Hansson O; Schneider JA
    Acta Neuropathol; 2023 Jul; 146(1):1-11. PubMed ID: 37031430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer's Disease Pathology.
    Wennström M; Schultz N; Gallardo PM; The Netherlands Brain Bank ; Serrano GE; Beach TG; Bose S; Hansson O
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology.
    Therriault J; Woo MS; Salvadó G; Gobom J; Karikari TK; Janelidze S; Servaes S; Rahmouni N; Tissot C; Ashton NJ; Benedet AL; Montoliu-Gaya L; Macedo AC; Lussier FZ; Stevenson J; Vitali P; Friese MA; Massarweh G; Soucy JP; Pascoal TA; Stomrud E; Palmqvist S; Mattsson-Carlgren N; Gauthier S; Zetterberg H; Hansson O; Blennow K; Rosa-Neto P
    Mol Neurodegener; 2024 Jan; 19(1):2. PubMed ID: 38185677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
    Salvadó G; Ossenkoppele R; Ashton NJ; Beach TG; Serrano GE; Reiman EM; Zetterberg H; Mattsson-Carlgren N; Janelidze S; Blennow K; Hansson O
    EMBO Mol Med; 2023 May; 15(5):e17123. PubMed ID: 36912178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease.
    Ashton NJ; Benedet AL; Pascoal TA; Karikari TK; Lantero-Rodriguez J; Brum WS; Mathotaarachchi S; Therriault J; Savard M; Chamoun M; Stoops E; Francois C; Vanmechelen E; Gauthier S; Zimmer ER; Zetterberg H; Blennow K; Rosa-Neto P
    EBioMedicine; 2022 Feb; 76():103836. PubMed ID: 35158308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
    Meyer PF; Ashton NJ; Karikari TK; Strikwerda-Brown C; Köbe T; Gonneaud J; Pichet Binette A; Ozlen H; Yakoub Y; Simrén J; Pannee J; Lantero-Rodriguez J; Labonté A; Baker SL; Schöll M; Vanmechelen E; Breitner JCS; Zetterberg H; Blennow K; Poirier J; Villeneuve S;
    Ann Neurol; 2022 Apr; 91(4):548-560. PubMed ID: 35084051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Ossenkoppele R; van der Kant R; Hansson O
    Lancet Neurol; 2022 Aug; 21(8):726-734. PubMed ID: 35643092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.